Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 37 Issue 5, May 2019

Engineered macrophages as diagnostics

A depiction of a cell-based sensor for cancer. Aalipour et al. engineer macrophages to express reporter proteins traceable in the blood when they activate the arginase-1 promoter.

See Aalipour et al.

Image: Jim Strommer, Stanford University. Cover Design: Erin Dewalt.

Editorial

  • Nature Biotechnology’s peer review trial with Code Ocean highlights the importance of ‘containers’ in enhancing software usability, reproducibility and code-writing in academia.

    Editorial

    Advertisement

Top of page ⤴

News

Top of page ⤴

Correspondence

Top of page ⤴

Features

  • 2018 was the year when the funding machine for privately held biotech companies went into overdrive, with mega-rounds and rapid flotations. John Hodgson brings us this deep dive.

    • John Hodgson
    Feature
  • Patents

Top of page ⤴

News & Views

  • In vivo studies indicate that cytosine but not adenine base editors induce elevated levels of genome-wide off-target substitutions.

    • Jia Chen
    • Bei Yang
    • Li Yang
    News & Views
Top of page ⤴

Research

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Careers & Recruitment

  • Career Feature

    • A quarterly snapshot of job expansions, reductions and availability in the biotech and pharma sectors.

      • Michael Francisco
      Career Feature
  • People

    • A sample of goings-on in and around the biotech and pharmaceutical industry.

      People
Top of page ⤴

Search

Quick links